tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX

Vertex Pharmaceuticals (VRTX) Similar Stocks

Compare
6,503 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
$462.99
$117.47B
32.63
12.75%
16 Buy
6 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$400.69
$52.94B
1,666.76
64.72%
17 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$100.44
$19.72B
16.85
44.39%
9 Buy
8 Hold
1 Sell
Moderate Buy
Regeneron
$783.71
$82.37B
18.76
9.96%
16 Buy
6 Hold
1 Sell
Moderate Buy
Argenx Se
$849.95
$52.15B
39.93
34.48%
17 Buy
3 Hold
0 Sell
Strong Buy
BioNTech SE
$95.03
$22.85B
-36.12
-16.47%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRTX
Vertex Pharmaceuticals
462.99
54.23
13.27%
ALNY
Alnylam Pharma
400.69
162.72
68.38%
INCY
Incyte
100.44
31.21
45.08%
REGN
Regeneron
783.71
75.24
10.62%
ARGX
Argenx Se
849.95
223.64
35.71%
BNTX
BioNTech SE
95.03
-18.92
-16.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts